Carson Wealth (CWM LLC)
AGRX

Carson Wealth (CWM LLC)’s Agile Therapeutics AGRX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2
Closed – – 4892
2023
Q4 		$0 Hold
2
– – ﹤0.01% 4668
2023
Q3 		$0 Hold
2
– – ﹤0.01% 4680
2023
Q2 		$0 Sell
2
-1
-33% -$5 ﹤0.01% 4600
2023
Q1 		$0 Hold
3
– – ﹤0.01% 4461
2022
Q4 		$0 Hold
3
– – ﹤0.01% 4367
2022
Q3 		$0 Hold
3
– – ﹤0.01% 4295
2022
Q2 		$0 Hold
3
– – ﹤0.01% 4198
2022
Q1 		$1K Hold
3
– – ﹤0.01% 3468
2021
Q4 		$2K Buy
+3
New +$4.23K ﹤0.01% 3224

Other funds holding AGRX

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

Carson Wealth (CWM LLC)'s AGRX Position: Q1 2024 in Review

Carson Wealth (CWM LLC) sold out of Agile Therapeutics (AGRX) in Q1 2024, closing a stake of 2 shares.

Carson Wealth (CWM LLC) first reported a position in AGRX in Q4 2021 and held it in 9 quarters. The position peaked at $2K in Q4 2021. 1 fund tracked by Wall St. Rank holds AGRX as of Q1 2024.

  • Carson Wealth (CWM LLC) reported no remaining Agile Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 2 Agile Therapeutics shares in Q1 2024.
  • Carson Wealth (CWM LLC) first reported a position in Agile Therapeutics in Q4 2021 and held it in 9 quarters.
  • Carson Wealth (CWM LLC)'s Agile Therapeutics position peaked at $2K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Agile Therapeutics as of Q1 2024.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2024, filed 5 Apr 2024.